Cello Health buys Defined Health
Established in 1983, Defined Health helps clients build portfolios with services focused on defining value for early stage compounds.
It will work closely with Cello Health Consulting in areas such as early asset development and commercialisation and market access.
Stephen Highley, chairman of Cello Health, said: “Defined Health has achieved a strong reputation by working closely with clients to build and strengthen biotech development-stage assets. Understanding the commercial opportunity and applicability of early stage assets is of fundamental importance to our clients.”

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments